(Note: This is NOT an IPO. This is a NASDAQ uplisting from the OTC Pink Market with the proposed NASDAQ symbol of “JETR” – a public offering of 2.88 million shares (2,875,000 shares) at the assumed offering price of $4.00. A 1-for-6 reverse stock split will take effect immediately after the effectiveness of this offering […]

Note: New Ruipeng Pet Group Inc. withdrew its plans for a U.S. IPO in a letter to the SEC dated June 6, 2024. The Chinese company had filed its F-1 on Jan. 23, 2023, but it had not disclosed terms. We are China’s largest one-stop pet care platform. We operate more than 1,900 pet hospitals […]

(Note: This is NOT an IPO. This is a NASDAQ uplisting from the Tel Aviv Stock Exchange, where the stock’s last reported sale price was US$20.96 on Feb. 2, 2023, according to the prospectus. Enlight’s SEC filing calls the deal an “initial public offering” but it’s not; the stock already trades in Tel Aviv. IPOScoop […]

(Note: 5 Edge Acquisition Corp. withdrew its plans for its SPAC IPO in an SEC filing dated Jan. 18, 2023. The blank check company filed its S-1 in March 2021.) We  intend to focus our search for target companies on the telecom sector.  We intend to focus our search within the TMT sector (on areas) […]

Mineralys Therapeutics is a clinical biotechnology company developing a therapy for cardiorenal disease.  We are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI) that we are initially developing for the treatment of […]

Top KingWin offers financial advisory and other services to entrepreneurs and executives involved with small and medium-sized enterprises (SMEs) in China.  (Incorporated in the  Cayman Islands) We provide a number of important business services in China to young and emerging companies, including (i) corporate business training services, which mainly focus on advanced knowledge and new […]

Squarex Pharmaceutical Corp. is a Phase 2 biotech developing a therapy to prevent cold sores. We are a late-clinical-stage pharmaceutical company developing a drug that is intended to improve immune function to reduce severity and incidence of infectious disease with an initial focus on oral herpes. Our drug SQX770 has completed a Phase 1 and […]

(Note: Hesai Group is a holding company incorporated in the Cayman Islands. Hesai Group is offering the American Depositary Shares (ADS) in this IPO – and not the underlying business and its subsidiaries operating in mainland China. Each ADS will represent an undetermined number (at the present date of Jan. 17, 2023) of Class B […]

Our mission is to reinvent how we take care of ourselves through the power of coaching and to usher in a new era of health, happiness, and longevity. We are Forme, a digital fitness platform that combines premium connected fitness hardware products with personal training and coaching (from real humans) to deliver an immersive experience […]

Mangoceuticals, Inc. provides relief for erectile dysfunction (ED) in men through telehealth services.   We plan to connect consumers to licensed healthcare professionals through our recently launched website at www.MangoRX.com for the provision of care via telehealth on our customer portal and plan to also provide access for customers to a licensed pharmacy for online fulfillment […]